Skip to content
Catalyst

PapersPMID:41053771

Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.

BMC complementary medicine and therapies2025The record ↗

  1. Finding, moderate evidenceno difference foundVisual analogue scale pain intensity

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “In the between-group analysis, no significant differences were observed in VAS hand pain at rest, VAS hand pain during activity, VAS hand morning stiffness, DASH score, hand grip, pinch strength and rescue drug usage at 1, 3, and 6 months.”
    Study
    RCT
    Participants
    27
    Dose studied
    170 mg/day curcuminoids (turmeric powder capsules, 28.75 mg curcuminoids per capsule, two capsules three times daily) for 3 months
    Population
    patients over 50 years with hand osteoarthritis, pain during activity, between-group at 1, 3 and 6 months

Study record

Design
randomised controlled trial
Species
human
Population
patients over 50 years old diagnosed with hand osteoarthritis
Participants
27
Comparator
placebo
Duration
183 days
Endpoints measured
15